ESTUDIO DE FASE III, ALEATORIZADO, MULTICÉNTRICO, CON GRUPOS PARALELOS Y DE AUSENCIA DE INFERIORIDAD PARA EVALUAR LA EFICACIA, LA SEGURIDAD Y LA TOLERABILIDAD DEL CAMBIO A DOLUTEGRAVIR MÁS LAMIVUDINA EN ADULTOSINFECTADOS POR EL VIH 1 CON SUPRESIÓN VIROLÓGICA.

Datos básicos

Código:
204862
Protocolo:
204862
EUDRACT:
2015-004401-17
NCT:
Centro:
HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
Dotación:
Año de incio:
2018
Año de finalización:
2020
ENSAYO CLÍNICO INTERNACIONAL

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

VIIV HEALTHCARE UK LIMITED

Resultados del Ensayo Clínico


[Translated article] Cybersecurity: a priority for pharmacy services in the age of artificial intelligence

Marin, Cayetano M. Hernandez, Monte-Boquet, Emilio, Andres, Jose Luis Poveda

Editorial Material. 10.1016/j.farma.2024.08.009. 2024

  • Open Access.

[Translated article] Good humanisation practices in the healthcare of patients with rare diseases in Pharmacy Services

Company Albir MJ, Andrés JLP, Solsona MDE

Article. 10.1016/j.farma.2023.10.004. 2024


[Translated article] New challenges in advanced therapies.

Megías-Vericat JE; (...); Poveda Andrés JL

Article. 10.1016/j.farma.2024.05.001. 2024


[Translated article] Pharmacokinetic-guided switching from standard half-life factor VIII to extended half-life pegylated factor VIII in haemophilia A therapy in clinical practice.

Chovi-Trull, Maria; (...); Andres, Jose Luis Poveda

Article. 10.1016/j.farma.2024.12.007. 2025


[Translated article] Real-world effectiveness and safety of nivolumab in patients with relapsed or refractory classical Hodgkin lymphoma.

Fernandez, Laura Lorente; (...); Andres, Jose Luis Poveda

Article. 10.1016/j.farma.2024.09.006. 2024

  • Open Access.

2019 SEFH National Survey: service portfolio, care activities, education and research in Spain's hospital pharmacy departments.

Pérez-Encinas M; (...); Calleja-Hernández MÁ

Article. 10.7399/fh.11611. 2021


A multicriteria decision analysis (MCDA) applied to three long-term prophylactic treatments for hereditary angioedema in Spain

Zozaya, Neboa; (...); Hidalgo-Vega, Alvaro

Article. 10.33393/grhta.2022.2333. 2022


A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases.

Zozaya, Neboa; (...); Verde, Luis

Article. 10.1017/S0266462322000459. 2022


A Multiple Stakeholder Multicriteria Decision Analysis in Diabetic Macular Edema Management: The MULTIDEX-EMD Study.

de Andrés-Nogales F; (...); Martínez-Olmos J

Article. 10.1007/s41669-020-00201-2. 2020


A MULTI-STAKEHOLDER MULTICRITERIA DECISION ANALYSIS IN DIABETIC MACULAR EDEMA. MULTIDEX-EMD STUDY.

Casado, MA; (...); Grp MULTIDEX-EMD

Meeting Abstract. 10.1016/j.jval.2018.09.2545. 2018


A new definition and refocus of pharmaceutical care: the Barbate Document

Morillo-Verdugo R; (...); Poveda-Andrés JL

Article. 10.7399/fh.11389. 2020


A NKp80-Based Identification Strategy Reveals that CD56 neg NK Cells Are Not Completely Dysfunctional in Health and Disease.

Orrantia A; (...); Borrego F

Article. 10.1016/j.isci.2020.101298. 2020


A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes.

Santos JR; (...); Paredes R

Article. 10.1093/ofid/ofad542. 2023


A young patient with fever after heart transplantation

Ramos, A; (...); Bouza, E

Editorial Material. 2018


ACUTE PARAPARESIS AS CLINICAL PRESENTATION OF VERTEBRAL OSTEOMYELITIS

Fragio-Gil, JJ; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2019-eular.6662. 2019


Adherence and adverse events of intraperitoneal chemotherapy in optimally debulked ovarian cancer patients: Real-life study.

Ballesta-López O; (...); Poveda-Andrés JL

Article. 10.1177/1078155220915953. 2020


Adverse outcomes of first-line integrase inhibitor-based single-tablet antiretroviral regimens in the Spanish VACH cohort

Teira, R; (...); Geijo, P

Meeting Abstract. 2018

  • Open Access.

An evidence-based bundle improves the quality of care and outcomes of patients with candidaemia

Cardozo, C; (...); Garcia-Vidal, C

Article. 10.1093/jac/dkz491. 2020


An outbreak due to Candida auris with prolonged colonisation and candidaemia in a tertiary care European hospital

Ruiz-Gaitan, A; (...); Peman, J

Article. 10.1111/myc.12781. 2018


Analysing criteria for price and reimbursement of orphan drugs in Spain.

Badia, X; (...); Tort, M

Article. 10.7399/fh.11147. 2019


Analysis of chemical contamination by hazardous drugs with BD HD Check(R) system in a tertiary hospital

Valero García S; (...); Poveda Andrés JL

Article. 10.1177/10781552211038518. 2021


Antimicrobial stewardship programme implementation in a medical ward

Ruiz, J; (...); Poveda, JL

Article. 2018


Antimicrobial stewardship programme in critical care medicine: A prospective interventional study

Ruiz, J; (...); Catellanos, A

Article. 10.1016/j.medin.2017.07.002. 2018


Anti-neutrophil cytoplasmic antibody-positive vasculitis presenting with periaortitis and muscle vasculitis in a patient with chronic Chagas disease.

Garcia-Bustos V; (...); Moral Moral P

Letter. 10.1080/03009742.2019.1701073. 2020


Anti-neutrophil cytoplasmic antibody-positive vasculitis presenting with periaortitis and muscle vasculitis in a patient with chronic Chagas disease: comment on the letter by Garcia-Bustos et al Reply

Garcia-Bustos V; (...); Moral Moral P

Letter. 10.1080/03009742.2020.1756401. 2020


Antiretroviral therapy without nucleoside reverse transcriptase inhibitors: dual therapy with darunavir/p and rilpivirine. Safety and efficacy in clinical practice. RIDAR 2

Arazo, P; (...); Pasquau, J

Meeting Abstract. 2018

  • Open Access.

Assessing the value of moderate-to-severe atopic dermatitis treatment using multi-criteria decision analysis (MCDA).

Pereyra-Rodríguez JJ; (...); Ortiz de Frutos FJ

Letter. 10.1111/jdv.19432. 2023


Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients.

Iglesias Gómez R; (...); Poveda Andrés JL

Article. 10.1136/ejhpharm-2021-002741. 2021


Bayesian pharmacokinetic individualization of prophylaxis with recombinant factor VIII in severe or moderate hemophilia A

Megias-Vericat, JE; (...); Bonanad, S

Meeting Abstract. 2018


Bayesian pharmacokinetic-guided prophylaxis with recombinant factor VIII in severe or moderate haemophilia A

Megias-Vericat, JE; (...); Poveda, JL

Article. 10.1016/j.thromres.2018.12.027. 2019


Bictegravir/emtricitabine/tenofovir alafenamide as first-line treatment in naïve HIV patients in a rapid-initiation model of care: BIC-NOW clinical trial.

Tenorio CH; (...); Vallecillos CG

Article. 10.1016/j.ijantimicag.2024.107164. 2024


Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study.

Fernandez Rivera C; (...); Hernandez D

Article. 10.1111/ctr.14550. 2022


Cellulitis in adult patients: A large, multicenter, observational, prospective study of 606 episodes and analysis of the factors related to the response to treatment

Collazos, J; (...); Asensi, V

Article. 10.1371/journal.pone.0204036. 2018


Central nervous system infections in immunocompromised patients

Castro, I; (...); Salavert, M

Article. 2018


Circulating extracellular vesicles in sera of chronic patients as a method for determining active parasitism in Chagas disease

Lozano, Noelia; (...); Osuna, Antonio

Article. 10.1371/journal.pntd.0012356. 2024


Clinical benefits of a Bayesian model for plasma-derived factor VIII/VWF after one year of pharmacokinetic-guided prophylaxis in severe/moderate hemophilia A patients

Megias-Vericat, JE; (...); Poveda, JL

Article. 10.1016/j.thromres.2021.07.009. 2021


Clinical pharmacy services: from cost-effectiveness analysis to a productivity indicators model

Nogueras, A; (...); Calleja, MA

Letter. 10.1136/ejhpharm-2019-001905. 2019


Clinicoepidemiological characteristics of viral hepatitis in migrants and travellers of the plus Redivi network

Henriquez-Camacho, C; (...); Redivi Study Grp

Article. 10.1016/j.tmaid.2019.02.001. 2019


Collaborative model of home delivery program in haemophilia through an association of patients

Megias-Vericat, JE; (...); Bonanad, S

Meeting Abstract. 2018


Comparison of antiretroviral treatment initiation in HIV newly diagnosed adolescents in Spain

Torres-Fernandez, D.; (...); Navarro, M. L.

Meeting Abstract. 2019


Comparison of pharmacokinetic estimates using generic and specific population pharmacokinetic models of plasma-derived factor VIII/VWF using WAPPS-Hemo

Megias-Vericat, JE; (...); Poveda, JL

Meeting Abstract. 2020


COMPUTER TOMOGRAPHY GUIDED BIOPSY YIELD IN PYOGENIC VERTEBRAL OSTEOMYELITIS. AN EXAMINATION OF INFLUENCING FACTORS

Fragio-Gil, JJ; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2019-eular.6627. 2019


Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.

Montoro-Ronsano JB; (...); Soto-Ortega I

Article. 10.1016/j.farma.2023.01.003. 2023


Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.

Montoro-Ronsano, Jose Bruno; (...); Soto-Ortega, Inmaculada

Article. 10.1016/j.farma.2023.04.002. 2023


COST MINIMIZATION ANALYSIS OF RITUXIMAB BIOSIMILAR VERSUS REFERENCE RITUXIMAB IN THE TREATMENT OF FOLLICULAR LYMPHOMA

Gironella, M.; (...); Oyaguez, I

Meeting Abstract. 2019

  • Open Access.

COST-EFFECTIVENESS ANALYSIS OF DIFELIKEFALIN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE ASSOCIATED-PRURITUS IN SPAIN

Sanchez-Alvarez, Emilio E.; (...); Hernaez Colque, M.

Meeting Abstract. 2024


Cost-effectiveness of Cladribine Tablets and fingolimod in the treatment of relapsing multiple sclerosis with high disease activity in Spain.

Poveda JL; (...); Torres C

Article. 10.1080/14737167.2019.1635014. 2020


COST-EFFECTIVENESS OF CLADRIBINE TABLETS AND FINGOLIMOD IN THE TREATMENT OF REMITTING MULTIPLE SCLEROSIS WITH HIGH DISEASE ACTIVITY IN SPAIN

Trillo, JL; (...); Torres, C

Meeting Abstract. 10.1016/j.jval.2018.09.2029. 2018


COSTS OF THE MANAGEMENT OF HEMOPHILIA A WITH INHIBITORS IN SPAIN

Bonanad, S; (...); Gonzalez-Dominguez, A

Meeting Abstract. 2020


Costs of the management of hemophilia A with inhibitors in Spain

Bonanad, S; (...); Gonzalez-Dominguez, A

Article. 10.33393/grhta.2021.2234. 2021


Cross-sectional comparative study of pharmacokinetics and efficacy between sucrose-formulated recombinant factor VIII (Kogenate (R)) and BAY 81-8973 (KovaltryA (R)) in patients with severe or moderate haemophilia A in prophylaxis

Megias-Vericat, JE; (...); Poveda, JL

Letter. 10.1111/hae.13733. 2019


Cross-Sectional Comparative Study of PK-Guided Switch between Standard Half-Life and Extended Half-Life Factor VIII Products

Eduardo Megias, Juan; (...); Iorio, Alfonso

Meeting Abstract. 10.1182/blood-2019-127946. 2019


Current management of CMV infection in cancer patients (solid tumors). Epidemiology and therapeutic strategies.

Garcia-Bustos, Victor; (...); Blanes, Marino

Article. 10.37201/req/s03.16.2022. 2022


Cutaneous and mucocutaneous leishmaniasis: experience of a Mediterranean hospital.

Garrido-Jareño M; (...); Pemán-García J

Article. 10.1186/s13071-020-3901-1. 2020


Cybersecurity, a priority for pharmacy services in the age of artificial intelligence.

Hernández Marín CM, Monte-Boquet E, Poveda Andrés JL

Editorial Material. 10.1016/j.farma.2024.08.001. 2024


Choice of the initial antiretroviral treatment for HIV-positive individuals in the era of integrase inhibitors

Asensi, V; (...); Pineda, JA

Article. 10.1371/journal.pone.0221598. 2019


Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57).

Podzamczer D; (...); Moreno S

Article. 10.1093/ofid/ofab595. 2022


Daunorubicin and cytarabine for certain types of poor-prognosis acute myeloid leukemia: a systematic literature review

Megias-Vericat, JE; (...); Montesinos, P

Review. 10.1080/17512433.2019.1573668. 2019


Defining a set of standardised outcome measures for newly diagnosed patients with multiple myeloma using the Delphi consensus method: the IMPORTA project

Blade, J; (...); Lizan, L

Article. 10.1136/bmjopen-2017-018850. 2018


Design and rationale for a real-world prospective, multicenter registry of myocardial revascularization failure and secondary revascularization: The REVASEC study.

Salinas P; (...); Escaned J

Article. 10.1016/j.carrev.2021.11.015. 2021


Detection and treatment of Candida auris in an outbreak situation: risk factors for developing colonization and candidemia by this new species in critically ill patients

Ruiz-Gaitan, Alba; (...); Peman, Javier

Article. 10.1080/14787210.2019.1592675. 2019


Determinants of Restoration of CD4 and CD8 Cell Counts and Their Ratio in HIV-1-Positive Individuals With Sustained Virological Suppression on Antiretroviral Therapy

Gras, L; (...); Antiretroviral Therapy Cohort

Article. 10.1097/QAI.0000000000001913. 2019


Determining the value contribution of emicizumab (Hemlibra (R)) for the prophylaxis of haemophilia A with inhibitors in Spain by multi-criteria decision analysis

Alvarez-Roman, MT; (...); Badia, X

Article. 10.1177/2284240319880534. 2019


DETERMINING THE VALUE OF EMICIZUMAB FOR THE PROPHYLAXIS OF SEVERE HAEMOPHILIA A PATIENTS WITHOUT INHIBITORS IN SPAIN BY MULTI-CRITERIA DECISION ANALYSIS (MCDA)

Alvarez, E.; (...); Badia, F. J.

Meeting Abstract. 2019


Determining value in the treatment of activated PI3Kdelta syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders.

Abad, Maria Reyes; (...); Gil, Alicia

Article. 10.33393/grhta.2024.3041. 2024


Determining what represents value in the treatment of prurigo nodularis and its key unmet needs in Spain through Multi-Criteria Decision Analysis

Silvestre, Juan Francisco; (...); Serra-Baldrich, Esther

Article. 10.1002/jvc2.275. 2024


DEVELOPMENT AND VALIDATION OF A MCDA FRAMEWORK FOR EVALUATION AND DECISION-MAKING OF ORPHAN DRUGS IN SPAIN

Poveda, J. L.; (...); Vitoria, I

Meeting Abstract. 2019


Development and validation of an MCDA framework for evaluation and decision-making of orphan drugs in Spain

Badia, X; (...); Poved, JL

Article. 10.1080/21678707.2019.1652163. 2019


Differences in epidemiology and mortality between men and women with HIV infection in the CoRIS cohort from 2004 to 2014.

Muñoz Hornero C; (...); Pérez-Elías MJ

Article. 10.1016/j.eimc.2020.05.021. 2021


Differences in epidemiology and mortality between men and women with HIV infection in the CoRIS cohort from 2004 to 2014.

Muñoz Hornero C; (...); Pérez-Elías MJ

Article. 10.1016/j.eimce.2021.07.003. 2021


Doctor, my patient has CDI and should continue to receive antibiotics. The (unresolved) risk of recurrent CDI.

Castro I; (...); Salavert M

Article. 2019


Does Autoimmunity Play a Role in the Immunopathogenesis of Vasculitis Associated With Chronic Chagas Disease?

Garcia-Bustos, V; (...); Munoz, EC

Editorial Material. 10.3389/fcimb.2021.671962. 2021


DOLAVI Real-Life Study of Dolutegravir Plus Lamivudine in Naive HIV-1 Patients (48 Weeks).

Hidalgo-Tenorio, Carmen; (...); Garcia-Vallecillos, Coral

Article. 10.3390/v14030524. 2022


Dolutegravir plus rilpivirine: benefits beyond viral suppression: DORIPEX retrospective study.

Troya, Jesus; (...); Buzon, Luis

Article. 10.1097/MD.0000000000029252. 2022


Durability of first-line antiretroviral regimens in the era of integrase inhibitors: a cohort of HIV-positive individuals in Spain, 2014-2015.

Jarrin I; (...); Cohort of the Spanish HIV

Article. 10.3851/IMP3297. 2019


Dynamics of creatinine estimated glomerular filtration rate using one or more antiretrovirals that inhibit creatinine tubular secretion.

Perez Elias MJ; (...); Martinez E

Article. 10.1093/jac/dkaa547. 2021


Early Detection of Cancer and Precancerous Lesions in Persons with HIV through a Comprehensive Cancer Screening Protocol.

Gutierrez, Felix; (...); Masia, Mar

Article. 10.1093/cid/ciae359. 2024


Economic impact of optimising antiretroviral treatment in human immunodeficiency virus-infected adults with suppressed viral load in Spain, by implementing the grade A-1 evidence recommendations of the 2015 GESIDA/National AIDS Plan

Ribera, E; (...); Hernandez-Novoa, B

Article. 10.1016/j.eimc.2016.11.015. 2018


Efecto de la adición de fortificantes y de módulo de proteínas en la osmolalidad de la leche materna donada.

Torres Martínez E; (...); Vento M

Article. 10.1016/j.anpedi.2020.03.009. 2020


Effect of Influenza Vaccination Inducing Antibody Mediated Rejection in Solid Organ Transplant Recipients

Cordero, E; (...); Perez-Romero, P

Article. 10.3389/fimmu.2020.01917. 2020


Effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in HIV late presenters

Corona, Diana; (...); Rivero, Antonio

Article. 10.1016/j.ijantimicag.2023.107016. 2024


Effectiveness and safety of integrase strand transfer inhibitors in Spain: a prospective real-world study.

Santos JR; (...); Paredes R

Article. 10.3389/fcimb.2023.1187999. 2023


Effectiveness and tolerability of dolutegravir and abacavir/lamivudine administered as two separate pills compared to their equivalent single-tablet regimen in treatment-naive and treatment-experienced patients

Suarez-Garcia, I.; (...); Jarrin, I.

Meeting Abstract. 2021


Effectiveness of Caplacizumab Nanobody in Acquired Thrombotic Thrombocytopenic Purpura Refractory to Conventional Treatment

Palanques-Pastor T; (...); Poveda Andrés JL

Article. 10.1159/000517813. 2021


Effectiveness, safety/tolerability of OBV/PTV/r DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice - Vie-KinD study.

Londoño MC; (...); García-Buey L

Article. 10.1371/journal.pone.0221567. 2019


Efficacy and safety of dolutegravir/rilpivirine in real-world clinical practice. GeSIDA study 1119.

Palacios, R.; (...); Santos, J.

Article. 10.1111/hiv.13489. 2023


eGFR-EPI changes among HIV patients who switch from F/TDF to F/TAF while maintaining the same third agent in the Spanish VACH cohort

Teira, R; (...); Espinosa, N

Article. 10.1080/25787489.2021.1955197. 2021


eLearning of pharmacokinetic monitoring in hemophilia with application in the clinical practice

Bonanad, S; (...); Megias-Vericat, JE

Meeting Abstract. 2018


Enterococcus spp. and Streptococcus spp. bloodstream infections: epidemiology and therapeutic approach.

Blanes Hernández R, Blanes Juliá M

Article. 10.37201/req/s01.01.2023. 2023


Epidemiological trends of HIV/HCV coinfection in Spain, 2015-2019.

Fanciulli C; (...); González Garcia J

Article. 10.1111/hiv.13229. 2022


Epidemiology and clinical description of Chagas disease in Valencia, Spain, from 2010 to 2020

Lozano, Noelia; (...); Calabuig, Eva

Article. 10.1016/j.actatropica.2024.107458. 2024


Etiology, diagnosis, and management of pneumonia in immunosuppressed patients.

Salavert Lleti, Miguel; (...); Garcia-Bustos, Victor

Article. 10.37201/req/s01.20.2022. 2022


EVALUATING REAL LIFE CRITERIA THAT COULD DRIVE PRICING & REIMBURSEMENT (P&R) APPROVAL OF ORPHAN DRUGS (ODS) IN SPAIN

Badia, F. J.; (...); Shepherd, J.

Meeting Abstract. 2019


Evolutionary and Phenotypic Characterization of Two Spike Mutations in European Lineage 20E of SARS-CoV-2.

Ruiz-Rodriguez P; (...); Coscolla M

Article. 10.1128/mBio.02315-21. 2021


Evolving understanding of cardiovascular, cerebrovascular and peripheral arterial disease in people living with HIV and role of novel biomarkers. A study of the Spanish CoRIS cohort, 2004-2015

Masia, M; (...); Gutierrez, F

Article. 10.1371/journal.pone.0215507. 2019


Executive Summary of the Consensus Statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Tropical Medicine and International Health (SEMTSI), the Spanish Association of Surgeons (AEC), the Spanish Society of Pneumology and Thoracic Surgery (SEPAR), the Spanish Society of Thoracic Surgery (SECT), the Spanish Society of Vascular and Interventional Radiology (SERVEI), and the Spanish Society of Paediatric Infectious Diseases (SEIP), on the Management of Cystic Echinococcosis.

Belhassen-Garcia M; (...); Velasco Pelayo L

Article. 10.1016/j.eimc.2019.10.015. 2020


Executive summary of the Consensus Statement of the Transplant Infection Study Group (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the National Transplant Organization (ONT) on the Selection Criteria of Donors of Solid Organs in relation to Infectious Diseases.

Len O; (...); Domínguez-Gil B

Article. 10.1016/j.eimc.2019.10.016. 2019


Experience of a fungal infection after cardiac surgery

Vicente-Martinez, L; (...); Argente, P

Article. 10.1016/j.redar.2019.01.012. 2019


Exploratory analysis for the implementation of antineoplastic logarithmic dose banding

Albert-Mari, A; (...); Poveda-Andres, JL

Article. 10.1007/s11096-018-0714-9. 2018


EXTENDED MULTICRITERIA DECISION ANALYSIS IN DIABETIC MACULAR EDEMA. MULTIDEX-EMD EXTENSION STUDY

F, de Andres-Nogales; (...); Martinez, M.

Meeting Abstract. 2019


Factors associated with late presentation for HIV care in adolescents in Spain

Epalza, Cristina; (...); Luisa Navarro, Maria

Article. 10.1111/hiv.13407. 2022


Factors associated with sepsis development in 606 Spanish adult patients with cellulitis

Collazos, J; (...); Asensi, V

Article. 10.1186/s12879-020-4915-1. 2020


Factors associated with the development of septic shock in patients with candidemia: a post hoc analysis from two prospective cohorts

Bassetti M; (...); Munoz, P

Article. 10.1186/s13054-020-2793-y. 2020


Factors associated with the number of drugs in darunavir/cobicistat regimens.

Martinez E; (...); Perez-Elias MJ

Article. 10.1093/jac/dkz399. 2020


Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn's Disease

Beltran, B; (...); Nos, P

Article. 10.1159/000492626. 2019


Fetal exposure to tofacitinib during the first trimester: A healthy newborn case report

Fernandez-Sanchez, M; (...); Poveda-Andres, JL

Article. 10.1002/bdr2.1942. 2021


Frequency and characteristics of HTLV in migrants: Results from the +Redivi collaborative network in Spain.

Norman FF; (...); López-Vélez R

Article. 10.1093/jtm/taac019. 2022


Genetic Variants Associated with Biological Treatment Response in Inflammatory Bowel Disease: A Systematic Review.

Plaza J; (...); Moret-Tatay I

Article. 10.3390/ijms25073717. 2024


Guide to Good Humanization Practices in Patients with Rare Diseases. who vadis

Poveda Andres, Jose Luis

Editorial Material. 2022


Haemodialysis significantly reduces serum levetiracetam levels inducing epileptic seizures: Case report

Company-Albir, MJ; (...); Poveda, JL

Article. 10.1111/jcpt.12568. 2017


Hazardous drugs levels in compounding area surfaces of Hospital Pharmacies Services: multicentric study

Valero-Garcia, S; (...); Spanish Hosp Pharmacy Units

Article. 10.7399/fh.10935. 2018


Healthcare Resource Utilization among Patients between 60-75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study

Solana-Altabella, Antonio; (...); Martinez-Cuadron, David

Article. 10.3390/cancers14081921. 2022


Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/hepatitis C virus-coinfected patients

Merchante, N; (...); GEHEP-002 Study Grp

Article. 10.1097/QAD.0000000000001809. 2018


Heterogeneity in Cystic Echinococcosis Management Among Spanish Centers: Results from a National Survey

Salvador, F; (...); Belhassen-Garcia, M

Article. 10.4269/ajtmh.19-0960. 2020


High incidence of pulmonary thromboembolism in hospitalized SARS-CoV-2 infected patients despite thrombo-prophylaxis.

El-Qutob D; (...); Carrera-Hueso FJ

Article. 10.1016/j.hrtlng.2022.02.003. 2022


High Plasma Levels of sTNF-R1 and CCL11 Are Related to CD4+T-Cells Fall in Human Immunodeficiency Virus Elite Controllers With a Sustained Virologic Control

Gutierrez-Rivas, M; (...); ECRIS Integrated Spanish AIDS Res

Article. 10.3389/fimmu.2018.01399. 2018


HIV/HBV coinfection in Spain: prevalence and clinical characteristics

Perez Latorre, L.; (...); Gonzalez-Garcia, J.

Meeting Abstract. 2019


HIV/HBV coinfection: temporal trends and patient characteristics, Spain, 2002 to 2018

Perez-Latorre, L; (...); Gonzalez-Garcia, J

Article. 10.2807/1560-7917.ES.2021.26.25.2000236. 2021


Hospital pharmacy initiatives for improving the management of patients with congenital coagulopathies

Bruno Montoro-Ronsano, Jose; (...); Alberto Vella, Vincenzo

Article. 10.7399/fh.11729. 2022


Hospitalization budget impact during the COVID-19 pandemic in Spain.

Carrera-Hueso, F. J.; (...); Crespo-Palomo, C.

Article. 10.1186/s13561-021-00340-0. 2021


How can artificial intelligence optimize value-based contracting?

Poveda, Jose Luis; (...); Medrano, Ignacio H.

Letter. 10.1186/s40545-022-00475-3. 2022


How do women living with HIV experience menopause? Menopausal symptoms, anxiety and depression according to reproductive age in a multicenter cohort

Suarez-Garcia, I; (...); Hernando, V

Article. 10.1186/s12905-021-01370-w. 2021


Human Immunodeficiency Virus/Hepatits C Virus Coinfection in Spain: Elimination Is Feasible, but the Burden of Residual Cirrhosis Will Be Significant

Berenguer, J; (...); GeSIDA 8514 Study Grp

Article. 10.1093/ofid/ofx258. 2018


IL7RA rs6897932 Polymorphism is Associated with Better CD4 + T-Cell Recovery in HIV Infected Patients Starting Combination Antiretroviral Therapy.

Resino S; (...); CoRIS and the HIV Biobank integrated in the Spanish AIDS Research Network Projec

Article. 10.3390/biom9060233. 2019


Impact of an enhanced screening program on the detection of non-AIDS neoplasias in patients with human immunodeficiency virus infection.

Masiá M; (...); Martínez E

Article. 10.1186/s13063-021-05777-6. 2021


Impact of an enhanced screening program on the detection of non-AIDS neoplasias in patients with human immunodeficiency virus infection (vol 22, 851, 2021)

Masia, M.; (...); Martinez, E.

Correction. 10.1186/s13063-023-07655-9. 2023


Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia.

Megías-Vericat JE; (...); Montesinos P

Article. 10.1080/10428194.2020.1839650. 2020


Impact of HIV on the survival of hepatocellular carcinoma in hepatitis C virus-infected patients

Merchante, N; (...); Pineda, JA

Article. 10.1097/QAD.0000000000002578. 2020


Impact of the therapeutic positioning report in the P&R process in Spain: analysis of orphan drugs approved by the European Commission and reimbursed in Spain from 2003 to 2019

Badia X; (...); Hernández C

Article. 10.1186/s13023-020-01507-4. 2020


Impact of voriconazole plasma concentrations on treatment response in critically ill patients

Ruiz, J; (...); Ramirez, P

Article. 10.1111/jcpt.12817. 2019


Implementation and results of a risk-sharing scheme for enzyme replacement therapy in lysosomal storage diseases

Edo-Solsona, MD, Vitoria-Minana, I, Poveda-Andres, JL

Article. 10.7399/fh.11262. 2020


Implication of Haemodiafiltration Flow Rate on Amikacin Pharmacokinetic Parameters in Critically Ill Patients

Ruiz-Ramos, J; (...); Ramirez, P

Article. 10.1159/000478969. 2018


Imported Arbovirus Infections in Spain, 2009-2018

Norman, FF; (...); Lopez-Velez, R

Article. 10.3201/eid2604.190443. 2020


Imported cysticercosis in Spain: A retrospective case series from the +REDIVI Collaborative Network.

Herrador Z; (...); López-Vélez R

Article. 10.1016/j.tmaid.2020.101683. 2020


Improvements in Patient-Reported Outcomes After 12 Months of Maintenance Therapy With Cabotegravir+Rilpivirine Long-Acting Compared With Bictegravir/Emtricitabine/Tenofovir Alafenamide in the Phase 3b SOLAR Study.

Mussini, Cristina; (...); van Wyk, Jean

Article. 10.1007/s10461-024-04490-0. 2024


Individualization of prophylaxis with recombinant factor VIII in severe or moderate hemophilia A

Vericat, JEM; (...); Bonanad, S

Meeting Abstract. 2018


INFECTIOUS SPONDYLODISCITIS: 7-YEAR ANALYSIS OF CLINICAL AND PROGNOSTIC VARIABLES IN A TERTIARY HOSPITAL

Fragio, J; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2018-eular.7272. 2018


Infective endocarditis due to Tropheryma whipplei: A current challenge

Dominguez-Massa, C; (...); Hornero-Sosa, F

Article. 10.1016/j.circv.2019.01.076. 2019


Influence of concomitant immunomodulators during maintenance therapy with Adalimumab in inflammatory bowel disease: looking for the ideal patient to use monotherapy

Bastida, G; (...); Nos, P

Meeting Abstract. 10.1093/ecco-jcc/jjy222.581. 2019


Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment

Megias-Vericat, JE; (...); Aliño SF

Article. 10.1080/10428194.2017.1323267. 2017


Influence of pharmacokinetic/pharmacodynamic ratio on vancomycin treatment response in paediatric patients with Staphylococcus aureus bacteremia.

Ruiz J; (...); Poveda JL

Article. 10.23736/S0026-4946.18.04978-2. 2018


Influence of polymorphisms in anthracyclines metabolism genes in the standard induction chemotherapy of acute myeloid leukemia.

Megías-Vericat JE; (...); Montesinos P

Article. 10.1097/FPC.0000000000000431. 2021


Integrase strand-transfer inhibitors for treatment of early HIV infection A case series

Teira, R; (...); Montero, M

Article. 10.1097/MD.0000000000016866. 2019


Interferon-free therapy for treating hepatitis C virus in difficult-to-treat HIV-coinfected patients

Minguez, C; (...); COINFECOVA-2 Study Grp

Article. 10.1097/QAD.0000000000001699. 2018


Intraperitoneal vancomycin in neonates during peritoneal dialysis: A case report

Company-Albir, MJ; (...); Poveda, JL

Article. 10.1111/jcpt.12842. 2019


Intravenous busulfan plus melphalan versus melphalan alone as conditioning regimen for patients with multiple myeloma

Blanes, M; (...); de la Rubia, J

Letter. 10.1007/s00277-019-03663-5. 2019


Intravenous Busulfan-Melphalan vs Melphalan as Preparative Regimen for Newly Diagnosed Multiple Myeloma: Long-Term Follow-Up of a Case-Control Study

Blanes, M; (...); de la Rubia, J

Meeting Abstract. 10.1016/j.clml.2019.09.473. 2019


Intravenous busulphan plus melphalan versus melphalan alone as conditioning regimen for newly diagnosed patients with multiple myeloma: Long-term follow-up of a matched case-controlled study

Blanes, M; (...); de la Rubia, J

Meeting Abstract. 2019


Intravitreal melphalan therapy for vitreous seeds in retinoblastoma: Implementation and outcomes of a new chemotherapy protocol.

Solana-Altabella A; (...); Poveda JL

Article. 10.1177/1078155220904410. 2020


Involvement of interleukin 6 in SARS-CoV-2 infection: siltuximab as a therapeutic option against COVID-19

Palanques-Pastor, T, Lopez-Briz, E, Andres, JLP

Article. 10.1136/ejhpharm-2020-002322. 2020


IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors.

Álvarez H; (...); Poveda E

Article. 10.3389/fimmu.2023.1257725. 2023


Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis.

Pozo-Rosich P; (...); Irimia P

Article. 10.1186/s10194-024-01747-w. 2024


Isavuconazole Pharmacokinetics in Critically Ill Patients: Relationship with Clinical Effectiveness and Patient Safety.

Martin-Cerezuela, Maria; (...); Ramirez Galleymore, Paula

Article. 10.3390/antibiotics13080706. 2024


Knowledge, attitudes and practices in HIV-related chronic inflammation and cardiovascular risk in Spain

Serrano-Villar, Sergio; (...); de Isla, Leopoldo Perez

Article. 10.1016/j.eimc.2023.07.005. 2024


Knowledge, attitudes and practices in HIV-related chronic inflammation and cardiovascular risk in Spain.

Serrano-Villar, Sergio; (...); Perez de Isla, Leopoldo

Article. 10.1016/j.eimce.2023.07.009. 2023


Laboral Cranio-Facial Cellulitis with Perichondritis and External Otitis, A Case Report

Moreno, Eloy Sempere, Barcelo, Santos Ibanez, Alonso, Marta Montero

Editorial Material. 10.1016/j.eimc.2024.02.008. 2024


Laboral cranio-facial cellulitis with perichondritis and external otitis, a case report.

Sempere Moreno, Eloy, Ibanez Barcelo, Santos, Montero Alonso, Marta

Case Reports. 10.1016/j.eimce.2024.04.004. 2024


Lack of impact of protease inhibitor resistance-associated mutations on the outcome of HIV-1-infected patients switching to darunavir-based dual therapy

Vizcarra, P; (...); Moral, SD

Article. 10.1080/23744235.2019.1694696. 2020


Long or complicated mpox in patients with uncontrolled HIV infection.

Corma-Gómez A; (...); Macías J

Article. 10.1002/jmv.29511. 2024


Long term follow-up in HCV infected patients with end stage chronic kidney disease after DAA therapy

Martinez-Camprecios, J; (...); Buti, M

Meeting Abstract. 2021


Long-term evolution in liver disease markers and immune and lipid profiles in vertically HIV/HCV-coinfected youths with sustained viral response after direct-acting antivirals therapy.

Tarancon-Diez, Laura; (...); Muñoz-Fernández MÁ

Article. 10.1016/j.biopha.2023.114587. 2023


Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy

Martinez-Camprecios, Joan; (...); Buti, Maria

Article. 10.1016/j.gastrohep.2022.12.004. 2023


Long-term impact of immediate versus deferred antiretroviral therapy on kidney health in people with HIV( vol 106, pg 136, 2024)

Pelchen-Matthews, Annegret; (...); Wyatt, Christina M.

Correction. 10.1016/j.kint.2024.10.002. 2024

  • Open Access.

Long-term impact of immediate versus deferred antiretroviral therapy on kidney health in people with HIV.

Pelchen-Matthews, Annegret; (...); Wyatt, Christina M.

Article. 10.1016/j.kint.2024.04.010. 2024


Losses to follow-up of HIV-infected people in the Spanish VACH cohort over the period between 2013 and 2014: The importance of sociodemographic factors

Teira, R; (...); Grp Estudio VACH

Article. 10.1016/j.eimc.2018.09.008. 2019


Low performance of ultrasound surveillance for the diagnosis of hepatocellular carcinoma in HIV-infected patients

Merchante, N; (...); GEHEP-002 Study Grp

Article. 10.1097/QAD.0000000000002065. 2019


Lower expression of plasma-derived exosome miR-21 levels in HIV-1 elite controllers with decreasing CD4 T cell count

Ruiz-de-Leon, MJ; (...); Sierra, O

Article. 10.1016/j.jmii.2018.07.007. 2019


Maintenance of virologic suppression and improvement in comorbidities after simplification to raltegravir plus boosted darunavir among treatment-experienced HIV-infected patients

Casado, JL; (...); De Santiago, AD

Article. 10.1177/0956462419896478. 2020


Management of flexible cavovarus foot in patients with Charcot-Marie-Tooth disease: midterm results.

Megías-Vericat JE; (...); Poveda-Andrés JL

Article. 2021

  • Open Access.

Manipulación de fármacos para su administración por gastrostomía endoscópica percutánea en pacientes con esclerosis lateral amiotrófica y nutrición enteral.

Vázquez Polo A; (...); Vázquez Costa JF

Article. 10.20960/nh.03946. 2022


Matching-Adjusted Indirect Comparison of Efficacy and Consumption of rVIII-SingleChain Versus Two Recombinant FVIII Products Used for Prophylactic Treatment of Adults/Adolescents with Severe Haemophilia A

Bonanad, S; (...); Santos, S

Article. 10.1007/s12325-021-01853-0. 2021


Metabolic Phenotyping in Prostate Cancer Using Multi-Omics Approaches.

Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor

Article. 10.3390/cancers14030596. 2022


Metyrapone as treatment in the neonatal McCune-Albright syndrome

de Mingo, Carmen; (...); Garcia-Robles, Ana

Article. 10.1515/jpem-2020-0036. 2020


Mild profile improvement of immune biomarkers in HIV/HCV-coinfected patients who removed hepatitis C after HCV treatment: A prospective study

Garcia-Broncano, P; (...); GESIDA 3603b Study Grp

Article. 10.1016/j.jinf.2019.09.020. 2020


Mitochondrial haplogroup H is related to CD4+T cell recovery in HIV infected patients starting combination antiretroviral therapy

Medrano, LM; (...); Spanish AIDS Res Network Project

Article. 10.1186/s12967-018-1717-y. 2018


Mitral repair results in endocarditis

Dominguez-Massa, C; (...); Montero-Argudo, JA

Article. 10.1016/j.circv.2020.08.005. 2020


Monitoring coagulation factors during surgery. A systematic review

Eduardo Megias-Vericat, Juan; (...); Luis Poveda-Andres, Jose

Review. 10.7399/fh.11766. 2021


Monitoring contamination of hazardous drug compounding surfaces at hospital pharmacy departments. A consensus Statement. Practice guidelines of the Spanish Society of Hospital Pharmacists (SEFH).

Valero-García S; (...); Delgado-Sánchez O

Article. 10.7399/fh.11655. 2021


Monitoring the quality of the hospital pharmacoterapeutic process by sentinel patient program.

Fernandez-Megia, MJ; (...); Poveda Andrés JL

Article. 10.7399/fh.10793. 2018


Monocyte Activation and Ageing Biomarkers in the Development of Cardiovascular Ischaemic Events or Diabetes in People with HIV.

Bernardino, Jose I.; (...); Rodes, Berta

Article. 10.3390/microorganisms11071818. 2023


Mortality in Perinatally HIV-infected Adolescents After Transition to Adult Care in Spain.

Berzosa Sánchez A; (...); Ramos Amador JT

Article. 10.1097/INF.0000000000003009. 2021


Multidrug resistant bacterial infections after liver transplantation: prevalence, impact and associated risk factors

Martin-Mateos, Rosa; (...); Albillos, Agustin

Meeting Abstract. 2022


Multidrug-resistant bacterial infections after liver transplantation: prevalence, impact, and risk factors.

Martin-Mateos R; (...); Albillos A

Article. 10.1016/j.jhep.2024.02.023. 2024


Multinational case-control study of risk factors for the development of late invasive pulmonary aspergillosis following kidney transplantation

Lopez-Medrano, F; (...); Swiss Transplant Cohort Study STCS

Article. 10.1016/j.cmi.2017.06.016. 2018


Multi-Omic Approaches to Breast Cancer Metabolic Phenotyping: Applications in Diagnosis, Prognosis, and the Development of Novel Treatments

Gomez-Cebrian, N; (...); Pineda-Lucena, A

Review. 10.3390/cancers13184544. 2021


National Survey of the SEFH-2019: portfolio of services, healthcare activity, teaching and research in Hospital Pharmacy Services in Spain (vol 45, pg 32, 2021)

Perez-Encinas, Montserrat; (...); Angel Calleja-Hernandez, Miguel

Correction. 10.7399/fh.11740. 2021


National Survey on the Use of Mobile Applications in Patients with Hemophilia and Other Coagulopathies

Eduardo Megias, Juan; (...); Poveda Andres, Jose Luis

Meeting Abstract. 10.1182/blood-2022-169938. 2022


New challenges of advanced therapies.

Megías-Vericat JE; (...); Poveda Andrés JL

Article. 10.1016/j.farma.2023.11.008. 2024


Observational study to evaluate discontinuation of monotherapy with cobicistat-boosted darunavir in patients with human immunodeficiency virus

Solana-Altabella, Antonio; (...); Poveda-Andres, Jose Luis

Article. 10.1097/MD.0000000000032208. 2022


ODs with a positive TPR conclusion, not subject to a conditional approval, and approved without requering a pass would be more likely to be reimbursed in Spain.

Poveda JL; (...); Badia X

Article. 10.1186/s13023-022-02610-4. 2023


Omics-Based Approaches for the Characterization of Pompe Disease Metabolic Phenotypes

Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor

Review. 10.3390/biology12091159. 2023


Online course of pharmacokinetic monitoring in hemophilia with application in the clinical practice

Bonanad, S; (...); Poveda, JL

Meeting Abstract. 2018


OPTIMIZING MANAGEMENT AND OUTCOMES OF ACTIVATED PHOSPHOINOSITIDE 3-KINASE DELTA SYNDROME (APDS) IN SPAIN: BEWAYAPDS PROJECT

Flores-Moreno, S.; (...); Gil, A.

Meeting Abstract. 2024


Outcomes by sex following treatment initiation with darunavir/cobicistat in a large Spanish cohort of the CODAR study (GeSIDA 9316)

Perez Elias, MJ; (...); CODAR Study Grp

Article. 10.1093/jac/dkz254. 2019


Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol

Garcia-Robles, Ana; (...); Carrascosa, MA

Article. 10.3389/fped.2020.00372. 2020


Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol (vol 8, 372, 2020)

Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta

Correction. 10.3389/fped.2021.834454. 2022


Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project

Morillo-Verdugo, R; (...); Diaz-Olmo, J

Article. 10.7399/fh.11719. 2021


Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project.

Morillo-Verdugo R; (...); Díaz-Olmo J

Article. 2021

  • Open Access.

Peritransplant Antiviral Treatment of Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Patients

Vinaixa, C; (...); Prieto, M

Letter. 10.1002/lt.25297. 2018


Pharmaceutical care to hospital outpatients during the COVID-19 pandemic. Telepharmacy

Margusino-Framiñán L; (...); Morillo-Verdugo R

Article. 10.7399/fh.11498. 2020


Pharmacogenetics in Response to Biological Agents in Inflammatory Bowel Disease: A Systematic Review.

Ballesta-Lopez, Octavio; (...); Poveda-Andres, Jose Luis

Article. 10.3390/ijms26041760. 2025

  • Open Access.

Pharmacogenetics of Metabolic Genes of Anthracyclines in Acute Myeloid Leukemia

Megias-Vericat, JE; (...); Montesinos, P

Review. 10.2174/1389200218666171101124931. 2018


Pharmacometabolomics by NMR in Oncology: A Systematic Review.

Gómez-Cebrián N; (...); Pineda-Lucena A

Article. 10.3390/ph14101015. 2021


Pharmacotherapeutic management of advanced therapy medicinal products

Luis Poveda-Andres, Jose; (...); Valero-Garcia, Silvia

Article. 10.7399/fh.13036. 2022


Pilot evaluation of home delivery programme in haemophilia

Megias-Vericat, JE; (...); Poveda-Andres, JL

Article. 10.1111/jcpt.12718. 2018


PK-GUIDED SWITCH BETWEEN STANDARD HALF-LIFE AND EXTENDED HALF-LIFE FACTOR VIII PRODUCTS

Vericat, JEM; (...); Iorio, A

Meeting Abstract. 2020


Pre and post intervention study of antiblastic drugs contamination surface levels at a Pharmacy Department Compounding Area using a closed system drug transfer device and a decontamination process

Valero, S; (...); Poveda, JL

Article. 10.1016/j.yrtph.2018.03.001. 2018


PRELIMINAR STUDY OF THERAPY ADHERENCE CONTROLLED BY PRESCRIPTION OF MEDICATION AND SELF-PERCEPTION ADHERENCE OF INFLAMMATORY CHRONIC DISEASE PATIENTS

Garcia, EG; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2019-eular.5937. 2019


Preparación y administración de perfusiones de insulina en neonatología: Encuesta nacional.

García-Robles A; (...); Aguar-Carrascosa M

Letter. 10.1016/j.anpedi.2020.06.008. 2021


Preparation and administration of insulin infusions in neonatology: A national survey.

Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta

Article. 10.1016/j.anpede.2020.06.015. 2021


Presence of good humanization practices in the healthcare of patients with rare diseases in Pharmacy Services

Company Albir MJ, Poveda Andrés JL, Edo Solsona MD

Article. 10.1016/j.farma.2023.06.0131130. 2024

  • Open Access.

Prevalence of people living with multidrug-resistant HIV and limited treatment options in Spain.

Llibre, Josep M; (...); Alcantara, Felipe Rodriguez

Article. 10.1111/hiv.13650. 2024


Primary resistance to integrase strand transfer inhibitors in Spain using ultrasensitive HIV-1 genotyping.

Casadellà M; (...); Noguera-Julian M

Article. 10.1093/jac/dkaa349. 2020


Proactive therapeutic drug monitoring and pharmacogenetic analysis in inflammatory bowel disease: A systematic review

Ballesta-Lopez, Octavio; (...); Luis Poveda-Andres, Jose

Review. 10.7399/fh.11780. 2021


Prospective study for the early detection of lung carcinoma in patients with HIV infection (GESIDA study 8815).

Valencia ME; (...); González J

Article. 10.1016/j.eimce.2024.05.005. 2024


Psychological distress in women and men living with HIV in Spain: a cross-sectional telephone survey

Garriga, C; (...); Rodriguez-Arenas, MA

Article. 10.1136/ebmental-2019-300138. 2020


Pyogenic Vertebral Osteomyelitis: Outcome Variables Analysis in a 116 Patients Cohort at a Tertiary Hospital during the Last 8 YEARS

Gil, JJF; (...); Ivorra, JAR

Meeting Abstract. 2018


Quantification of physical activity in adult patients with haemophilic arthropathy in prophylaxis treatment using a fitness tracker

Perez-Alenda, S; (...); Querol, F

Letter. 10.1111/hae.13388. 2018


Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR

Vigon, L; (...); Esteban, H

Article. 10.1038/s41598-019-48592-5. 2019


Real world effectiveness of standard of care triple therapy versus two-drug combinations for treatment of people living with HIV.

Teira, Ramon; (...); Berenguer, Juan

Article. 10.1371/journal.pone.0249515. 2021


Real-life experience with fidaxomicin in Clostridioides difficile infection: a multicentre cohort study on 244 episodes.

Escudero-Sánchez R; (...); Cobo J

Article. 10.1007/s15010-020-01567-5. 2021


Real-world persistence of E/C/F/TAF versus DTG+ABC/3TC regimens for treatment of HIV in a large Spanish cohort: VACH

Teira, R; (...); Gutierrez, M

Meeting Abstract. 2018

  • Open Access.

Reasons for noncompliance with the national guidelines for initial antiretroviral therapy of HIV-infected patients in Spain, 2010-2015

Gonzalez, J; (...); Cohort Spanish HIV Res Network Co

Article. 10.1016/j.eimc.2019.02.007. 2019


Recent infections among newly diagnosed cases of HIV infection in Spain, 2015-2016. National estimates using cohort data.

Hernando V; (...); CoRIS-HIV Biobank

Article. 10.1080/23744235.2021.1893377. 2021


Recomendaciones GEMICOMED/GEIRAS-SEIMC para el manejo de las infecciones y colonizaciones por Candida auris.

Alastruey-Izquierdo A; (...); en nombre de GEMICOMED GEIRAS-SEIMC

Abstract of Published Item. 10.1016/j.riam.2019.06.001. 2019


Response to direct acting antivirals in vertically HIV/HCV co-infected youths

Carrasco, I; (...); CoRISpe-Spanish Natl Cohort

Meeting Abstract. 2019

  • Open Access.

Response to direct-acting antivirals for hepatitis C treatment in vertically HIV/HCV co-infected patients

Carrasco, I; (...); Navarro, ML

Article. 10.1111/jvh.13308. 2020


Rickettsioses imported by travellers and migrants to Spain attended in the+Redivi network, 2009-2020.

Llenas-Garcia, Jara; (...); Perez-Molina, Jose A.

Article. 10.1093/jtm/taad050. 2023


Risk factors for unfavorable outcome and impact of early post-transplant infection in solid organ recipients with COVID-19: A prospective multicenter cohort study

Salto-Alejandre, S; (...); Cordero, E

Article. 10.1371/journal.pone.0250796. 2021


Role of HIV in the desire of procreation and motherhood in women living with HIV in Spain: a qualitative approach

Alvarez-del Arco, D; (...); CoRIS

Article. 10.1186/s12905-017-0483-y. 2018


Role of previous systemic antibiotic therapy on the probability of recurrence after an initial episode of Clostridioides difficile infection treated with vancomycin.

Merchante, Nicolas; (...); Merino, Esperanza

Article. 10.1093/jacamr/dlad033. 2023


Safety and Tolerability of More than Six Days of Tedizolid Treatment

Vendrell, MM; (...); Viladomiu, AS

Article. 10.1128/AAC.00356-20. 2020


Salvage therapy with topical posaconazole in lung transplant recipients with invasive Scedosporium infection.

Sole, A; (...); Peman, J

Article. 10.1111/ajt.14580. 2018


SARS-CoV-2 N protein IgG antibody detection employing nanoporous anodized alumina: A rapid and selective alternative for identifying naturally infected individuals in populations vaccinated with spike protein (S)-based vaccines

Esteve-Sanchez, Yoel; (...); Climent, Estela

Article. 10.1016/j.snb.2024.136378. 2024


SARS-COV-2 viral RNA detection through oligonucleotide-capped nanoporous anodic alumina supports.

Lopez-Palacios, Alba; (...); Climent, Estela

Article. 10.1016/j.snr.2025.100298. 2025


SEFH National Survey-2019: general characteristics, staffing, material resources and information systems in Spain's hospital pharmacy departments.

Pérez-Encinas M; (...); Calleja-Hernández MÁ

Article. 10.7399/fh.11565. 2020


Selection criteria of solid organ donors in relation to infectious diseases: A Spanish consensus.

Len O; (...); Domínguez-Gil B

Review. 10.1016/j.trre.2020.100528. 2020


Sex differences in hospitalized adult patients with cellulitis: A prospective, multicenter study.

Collazos J; (...); Asensi V

Article. 10.1016/j.ijid.2021.01.044. 2021


Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish Cohort

Teira, Ramon; (...); Curran, Adria

Article. 10.1007/s40121-022-00630-y. 2022


SMPTall man lettering application in medication information systems as a quality and safety strategy in hospital organization

Iglesias Gomez, Ruben; (...); Poveda Andres, Jose Luis

Article. 10.1111/jcpt.13703. 2022


Spatiotemporal Characteristics of the Largest HIV-1 CRF02_AG Outbreak in Spain: Evidence for Onward Transmissions

Kostaki, EG; (...); CoRIS

Article. 10.3389/fmicb.2019.00370. 2019


Switching to a dual regimen with the combination of boosted darunavir plus raltegravir in severely experienced patients: a multicentre, retrospective analysis

Casado, J; (...); de Santiago, AD

Meeting Abstract. 2018

  • Open Access.

Switching to bictegravir/ emtricitabine/tenofovir alafenamide plus darunavir/cobicistat in heavily antiretroviralexperienced, virologically suppressed HIV-infected adults receiving complex regimens: 48-week analysis

Podzamczer, D.; (...); Rivero, A.

Meeting Abstract. 2023


Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens.

Podzamczer, Daniel; (...); Rivero, Antonio

Article. 10.1093/jac/dkad285. 2023


Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia

Megías-Vericat JE; (...); Montesinos P

Review. 10.3390/pharmaceutics14040878. 2022


The algorithm used for the interpretation of doravirine transmitted drug resistance strongly influences clinical practice and guideline recommendations.

Guerrero-Beltrán C; (...); Moreno S

Article. 10.1093/jac/dkaa009. 2020


The association of salivary caffeine levels with serum concentrations in premature infants with apnea of prematurity

Garcia-Robles, Ana; (...); Saenz Gonzalez, Pilar

Article. 10.1007/s00431-022-04628-z. 2022


The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis.

Gil-Nagel A; (...); Gil A

Article. 10.1016/j.yebeh.2022.108711. 2022


The value of the reflective discussion in decision-making using multi-criteria decision analysis (MCDA): an example of determining the value contribution of tabelecleucel for the treatment of the Epstein Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD).

Badia, Xavier; (...); Valles, Joan-Antoni

Article. 10.1186/s13023-024-03324-5. 2024


The view of experts on initiatives to be undertaken to promote equity in the access to orphan drugs and specialised care for rare diseases in Spain: A Delphi consensus

Torrent-Farnell, J; (...); Lizan, L

Article. 10.1016/j.healthpol.2018.03.002. 2018


Topiramate pharmacokinetics in neonates undergoing therapeutic hypothermia and proposal of an optimised dosing schedule.

Marques MR; (...); Mangas-Sanjuan V

Article. 10.1111/apa.14944. 2020


Towards a symbiotic relationship between big data, artificial intelligence, and hospital pharmacy

Del Rio-Bermudez, C; (...); Poveda, JL

Editorial Material. 10.1186/s40545-020-00276-6. 2020


Toxic-metabolic encephalopathy induced by metronidazole and disulfiram: classics never die.

Chovi-Trull, Maria; (...); Poveda-Andres, Jose Luis

Article. 10.1136/ejhpharm-2024-004184. 2024


Transmitted drug resistance to antiretroviral drugs in Spain during the period 2019-2021.

Vinuela, Laura; (...); Garcia, Federico

Article. 10.1002/jmv.29287. 2023


Trends in imported infections among migrants and travellers to Spain: a decade of analysis through the +Redivi network (2012-2022).

Alkaissy Y; (...); Perez-Molina JA

Article. 10.1093/jtm/taae067. 2024


Trends in Imported Malaria during the COVID-19 pandemic, Spain (+Redivi Collaborative Network).

Norman, Francesca F.; (...); Perez-Molina, Jose A.

Article. 10.1093/jtm/taac083. 2022


Tuberculosis of the elbow: A rare form of presentation of extrapulmonary tuberculosis.

Castaño Aroca MJ; (...); Gil-Brusola, A

Letter. 10.1016/j.eimc.2018.08.002. 2019


Undetectable levels of adalimumab in clinical practice: Should we say goodbye to the drug?

Bejar, S; (...); Mateu, PN

Meeting Abstract. 2020


Unplanned pregnancies and social and partner support during pregnancy in Spanish women living with HIV.

Ruiz-Alguero, Marta; (...); Jarrin, Inma

Article. 10.1111/hiv.13469. 2023


Use and handling safety of Mini-Spike 2 (R) chemo and puresite for safe chemotherapy compounding in a hospital pharmacy

Garcia, SV; (...); Andres, JLP

Article. 10.1016/j.yrtph.2018.10.002. 2018


USE OF CAPLACIZUMAB IN THE ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA

Dominguez Hernandez, L.; (...); Gomez Segui, I

Meeting Abstract. 2019

  • Open Access.

Use of sera cell free DNA (cfDNA) and exovesicle-DNA for the molecular diagnosis of chronic Chagas disease.

Lozano N; (...); Osuna A

Article. 10.1371/journal.pone.0282814. 2023


VALUE CRITERIA FOR OUTCOMES BASED MANAGED ENTRY AGREEMENT OF CAR-T IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) THROUGH MCDA

Poveda, J. L.; (...); Lizan, L.

Meeting Abstract. 2023


VDR rs2228570 Polymorphism Is Related to Non-Progression to AIDS in Antiretroviral Therapy Naive HIV-Infected Patients

Jimenez-Sousa, MA; (...); LTNPs Cohort

Article. 10.3390/jcm8030311. 2019


VERTEBRAL OSTEOMYELITIS IN THE IMMUNOSUPPRESSED PATIENTS

Fragio-Gil, JJ; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2019-eular.6621. 2019

  • Open Access.

Campos de estudio

Compartir